Ionis Pharmaceuticals, Inc.
IONS
$32.96
$0.060.18%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -1,026.51% | 4.70% | 22.31% | -14.86% | 82.33% |
Total Depreciation and Amortization | -6.15% | -1.75% | -1.93% | 0.80% | -20.16% |
Total Amortization of Deferred Charges | 0.60% | -1.29% | 12.91% | 12.18% | 24.36% |
Total Other Non-Cash Items | 95.07% | -23.00% | 169.14% | -18.76% | 117.46% |
Change in Net Operating Assets | -572.70% | -129.99% | -197.89% | 17.24% | 142.06% |
Cash from Operations | -453.38% | -5.47% | -23.13% | -11.90% | 116.42% |
Capital Expenditure | -3,213.19% | -322.98% | 48.10% | 57.10% | 119.79% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 440.37% | -568.21% | -15.75% | 125.57% | -112.73% |
Cash from Investing | 355.36% | -595.98% | -10.16% | 123.37% | -112.59% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -117,123.68% | 99.93% | 99.99% | 0.00% | 99.92% |
Issuance of Common Stock | -98.95% | 13,200.13% | 8.62% | 822.23% | 11,783.97% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | 100.00% |
Cash from Financing | -208.33% | 1,637.32% | -98.22% | -95.21% | 179.82% |
Foreign Exchange rate Adjustments | -247.27% | 330.26% | -132.86% | -209.62% | -39.56% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -296.01% | 155.84% | -147.42% | -254.73% | 222.55% |